세계의 식품 알레르기 진단 및 치료 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)
Global Food Allergy Diagnostics And Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
상품코드:1555021
리서치사:Value Market Research
발행일:2024년 08월
페이지 정보:영문 170 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
식품 알레르기 진단 및 치료 시장의 세계 수요는 2023년 83억 6,000만 달러에서 2032년 175억 6,000만 달러에 육박할 것으로 추정되며, 2024년까지 연평균 8.59%의 CAGR을 기록할 것으로 예상됩니다.
식품 알레르기의 진단 및 치료에는 특정 식품 섭취로 인한 면역 반응인 식품 알레르기를 확인하고 관리하기 위해 고안된 다양한 검사와 치료가 포함됩니다. 진단 도구에는 피부 도말 검사, 혈액 검사, 경구 음식물 과제 등이 있으며, 이는 특정 알레르겐과 알레르기 반응의 심각성을 판단하는 데 도움이 됩니다. 치료적 접근법은 알레르기 반응을 줄이기 위해 알레르겐 회피 전략, 에피네프린과 같은 응급 약물, 경구 면역요법과 같은 새로운 치료법을 포함합니다. 이러한 개입은 식품 알레르기를 관리하고 심각한 알레르기 반응의 위험을 줄여 전반적인 건강 결과를 개선함으로써 환자의 삶의 질을 개선하는 데 매우 중요합니다.
시장 역학
세계 식품 알레르기 진단 및 치료 시장은 식품 알레르기의 유병률 증가와 효과적인 관리 솔루션에 대한 수요 증가로 인해 활성화되고 있습니다. 멀티플렉스 분석 및 유전자 검사와 같은 진단 기술의 발전으로 알레르겐을 보다 정확하고 포괄적으로 식별할 수 있게 되었습니다. 알레르겐 면역요법 및 생물학적 제제를 포함한 새로운 치료 접근법의 개발은 치료와 환자 예후를 개선할 수 있는 새로운 기회를 제공하고 있습니다. 식품 알레르기에 대한 인식이 높아지고 개별화된 관리 전략의 필요성이 대두되면서 전문적인 진단과 치료에 대한 수요가 증가하고 있습니다. 또한, 식품 알레르기 치료에 대한 규제 당국의 지원과 연구 자금 지원은 식품 알레르기 진단 및 치료 시장의 성장에 기여하고 있습니다. 의료 인프라의 확대와 예방의학에 대한 관심 증가도 시장 개척과 혁신의 기회를 창출하고 있습니다. 그러나 높은 치료 비용과 한정된 고급 진단 약품은 식품 알레르기 진단 및 치료 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
조사 보고서는 Porter's Five Forces 모델, 시장 매력도 분석, 밸류체인 분석을 다루고 있습니다. 이러한 도구는 산업 구조를 명확하게 파악하고 세계 수준에서 경쟁의 매력을 평가하는 데 도움이됩니다. 또한 이러한 도구는 식품 알레르기 진단 및 치료 세계 시장에서 각 부문을 포괄적으로 평가할 수 있습니다. 식품 알레르기 진단 및 치료 산업의 성장과 동향은 이 조사에 대한 전체적인 접근 방식을 제공합니다.
시장 세분화
식품 알레르기 진단 및 치료 시장 보고서의 이 섹션에서는 국가 및 지역 수준의 부문에 대한 자세한 데이터를 제공하여 전략가들이 향후 기회가 있는 각 제품 및 서비스의 타겟층을 식별하는 데 도움이 될 것입니다.
이 섹션에서는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카의 식품 알레르기 진단 및 치료 시장의 현재 및 미래 수요를 강조하는 지역 전망을 다룹니다. 또한, 이 보고서는 모든 주요 지역의 개별 애플리케이션 부문의 수요, 추정 및 예측에 초점을 맞추고 있습니다.
맞춤형 요구사항이 있는 경우, 저희에게 연락주시기 바랍니다. 당사의 조사팀은 고객의 요구에 따라 맞춤형 보고서를 제공할 수 있습니다.
The global demand for Food Allergy Diagnostics And Therapeutics Market is presumed to reach the market size of nearly USD 17.56 Billion by 2032 from USD 8.36 Billion in 2023 with a CAGR of 8.59% under the study period 2024-2032.
Food allergy diagnostics and therapeutics encompass a range of tests and treatments designed to identify and manage food allergies, which are immune responses triggered by the ingestion of certain foods. Diagnostic tools include skin prick tests, blood tests, and oral food challenges, which help determine specific allergens and the severity of the allergic reaction. Therapeutic approaches aim to mitigate allergic responses, including allergen avoidance strategies, emergency medications like epinephrine, and emerging treatments like oral immunotherapy. These interventions are crucial for managing food allergies and improving the quality of life for affected individuals by reducing the risk of severe allergic reactions and enhancing overall health outcomes.
MARKET DYNAMICS
The global food allergy diagnostics & therapeutics market is fuelled by the rising prevalence of food allergies and the growing demand for effective management solutions. Advances in diagnostic technologies, such as multiplex assays and genetic testing, provide more accurate and comprehensive identification of allergens. The development of novel therapeutic approaches, including allergen immunotherapy and biologics, offers new opportunities for treatment and improved patient outcomes. The propelling awareness of food allergies and the need for personalized management strategies are fuelling demand for specialized diagnostics and therapies. Additionally, regulatory support and funding for research into food allergy treatments are contributing to the growth of the food allergy diagnostics & therapeutics market. The expansion of healthcare infrastructure and the increasing focus on preventive care also create opportunities for market development & innovation. However, high treatment costs and limited availability of advanced diagnostics may hinder the growth of the food allergy diagnostics and therapeutics market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Food Allergy Diagnostics And Therapeutics. The growth and trends of Food Allergy Diagnostics And Therapeutics industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Food Allergy Diagnostics And Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
Diagnostics (Instruments, Consumables, Services, Tests (In Vivo/Skin (Skin Prick Test, Patch Test), In Vitro))
This section covers the regional outlook, which accentuates current and future demand for the Food Allergy Diagnostics And Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Food Allergy Diagnostics And Therapeutics market include Astellas Pharma Inc., Aimmune Therapeutics, Meridian Medical Technologies, Medeca Pharma AB, BioMeriux SA, Omega Diagnostics Group PLC, Cambridge Allergy Ltd, Immunomic Therapeutics Inc, Prota Therapeutics Pty Ltd, ALK-Abello Ltd, Hycor Biomedical, HOB Biotech Group Corp. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3. FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS - INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Allergen Source
3.7.3 Market Attractiveness Analysis By End-use
3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Diagnostics (Instruments, Consumables, Services, Tests (In Vivo/Skin (Skin Prick Test, Patch Test), In Vitro)) Historic and Forecast Sales By Regions
5.4. Therapeutics (Antihistamines, Epinephrine Auto-Injector) Historic and Forecast Sales By Regions
6. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY ALLERGEN SOURCE
6.1. Overview By Allergen Source
6.2. Historical and Forecast Data Analysis By Allergen Source
6.3. Peanuts Historic and Forecast Sales By Regions
6.4. Milk Historic and Forecast Sales By Regions
6.5. Eggs Historic and Forecast Sales By Regions
6.6. Fish Historic and Forecast Sales By Regions
6.7. Shellfish Historic and Forecast Sales By Regions
6.8. Tree Nuts Historic and Forecast Sales By Regions
6.9. Wheat Historic and Forecast Sales By Regions
6.10. Soy Historic and Forecast Sales By Regions
6.11. Others Historic and Forecast Sales By Regions
7. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY END-USE
7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals And Clinics Historic and Forecast Sales By Regions
7.4. Academic Research Institutes Historic and Forecast Sales By Regions
7.5. Diagnostics Laboratories Historic and Forecast Sales By Regions
8. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS COMPANIES
9.1. Food Allergy Diagnostics And Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Astellas Pharma Inc.
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Aimmune Therapeutics
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. Meridian Medical Technologies
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. Medeca Pharma AB
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. BioMeriux SA
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Omega Diagnostics Group PLC
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. Cambridge Allergy Ltd
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. Immunomic Therapeutics Inc
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
10.11. Prota Therapeutics Pty Ltd
10.11.1 Company Overview
10.11.2 Company Revenue
10.11.3 Products
10.11.4 Recent Developments
10.12. ALK-Abello Ltd
10.12.1 Company Overview
10.12.2 Company Revenue
10.12.3 Products
10.12.4 Recent Developments
10.13. Hycor Biomedical
10.13.1 Company Overview
10.13.2 Company Revenue
10.13.3 Products
10.13.4 Recent Developments
10.14. HOB Biotech Group Corp. Ltd
10.14.1 Company Overview
10.14.2 Company Revenue
10.14.3 Products
10.14.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
